41 related articles for article (PubMed ID: 38680423)
1. HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.
Wang SS; Carrington M; Berndt SI; Slager SL; Bracci PM; Voutsinas J; Cerhan JR; Smedby KE; Hjalgrim H; Vijai J; Morton LM; Vermeulen R; Paltiel O; Vajdic CM; Linet MS; Nieters A; de Sanjose S; Cozen W; Brown EE; Turner J; Spinelli JJ; Zheng T; Birmann BM; Flowers CR; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Albanes D; Weinstein SJ; Teras LR; Diver WR; Lax SJ; Travis RC; Kaaks R; Riboli E; Benavente Y; Brennan P; McKay J; Delfau-Larue MH; Link BK; Magnani C; Ennas MG; Latte G; Feldman AL; Doo NW; Giles GG; Southey MC; Milne RL; Offit K; Musinsky J; Arslan AA; Purdue MP; Adami HO; Melbye M; Glimelius B; Conde L; Camp NJ; Glenn M; Curtin K; Clavel J; Monnereau A; Cox DG; Ghesquières H; Salles G; Bofetta P; Foretova L; Staines A; Davis S; Severson RK; Lan Q; Brooks-Wilson A; Smith MT; Roman E; Kricker A; Zhang Y; Kraft P; Chanock SJ; Rothman N; Hartge P; Skibola CF
Cancer Res; 2018 Jul; 78(14):4086-4096. PubMed ID: 29735552
[TBL] [Abstract][Full Text] [Related]
2. Two Novel Human Leukocyte Antigen Alleles Are Associated with Decreased Risk of Onychomycosis in a Large Cohort of Danish Blood Donors.
Lindsø Andersen P; Jemec GBE; Erikstrup C; Didriksen M; Dinh KM; Mikkelsen S; Bruun MT; Hjalgrim H; Hansen TF; Sækmose SG; Ostrowski SR; Pedersen OB; Saunte DM
Skin Appendage Disord; 2023 Jun; 9(3):195-202. PubMed ID: 37325286
[TBL] [Abstract][Full Text] [Related]
3. The role of HLA variation in lymphoma aetiology and survival.
Zhong C; Cozen W; Bolanos R; Song J; Wang SS
J Intern Med; 2019 Aug; 286(2):154-180. PubMed ID: 31155783
[TBL] [Abstract][Full Text] [Related]
4. HLA variations in patients with diffuse large B-cell lymphoma and association with disease risk and prognosis: a case-control study.
Diamanti I; Fylaktou A; Verrou E; Vlachaki E; Sinakos M; Katodritou E; Ouranos K; Minti F; Gioula G
Front Genet; 2024; 15():1341822. PubMed ID: 38680423
[TBL] [Abstract][Full Text] [Related]
5. Association of KIR Genes Polymorphism and its HLA Ligands in Diffuse Large B-cell Lymphoma.
Daniela Maira C; Amanda Vansan M; Fernando G; Silvia M; Sofia L; Márcia D; Francisco José Penteado A; Jeane Eliete Laguila V; Cármino Antonio S
Clin Lymphoma Myeloma Leuk; 2023 Jun; 23(6):438-445. PubMed ID: 37105848
[TBL] [Abstract][Full Text] [Related]
6. The relationship between HLA class II polymorphisms and somatic deletions in testicular B cell lymphomas of Dutch patients.
Riemersma SA; Jordanova ES; Haasnoot GW; Drabbels J; Schuuring E; Schreuder GM; Kluin PM
Hum Immunol; 2006; 67(4-5):303-10. PubMed ID: 16720210
[TBL] [Abstract][Full Text] [Related]
7. HLA class II polymorphism in Egyptian children with lymphomas.
Al-Tonbary Y; Abdel-Razek N; Zaghloul H; Metwaly S; El-Deek B; El-Shawaf R
Hematology; 2004 Apr; 9(2):139-45. PubMed ID: 15203870
[TBL] [Abstract][Full Text] [Related]
8. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
9. A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients.
Tiercy JM; Rathinam SR; Gex-Fabry M; Baglivo E
Mol Vis; 2010 Mar; 16():353-8. PubMed ID: 20216938
[TBL] [Abstract][Full Text] [Related]
10. KIR-HLA gene diversities and susceptibility to lung cancer.
Hematian Larki M; Ashouri E; Barani S; Ghayumi SMA; Ghaderi A; Rajalingam R
Sci Rep; 2022 Oct; 12(1):17237. PubMed ID: 36241658
[TBL] [Abstract][Full Text] [Related]
11. The New Kid on the Block: HLA-C, a Key Regulator of Natural Killer Cells in Viral Immunity.
Vollmers S; Lobermeyer A; Körner C
Cells; 2021 Nov; 10(11):. PubMed ID: 34831331
[TBL] [Abstract][Full Text] [Related]
12. Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma.
Fangazio M; Ladewig E; Gomez K; Garcia-Ibanez L; Kumar R; Teruya-Feldstein J; Rossi D; Filip I; Pan-Hammarström Q; Inghirami G; Boldorini R; Ott G; Staiger AM; Chapuy B; Gaidano G; Bhagat G; Basso K; Rabadan R; Pasqualucci L; Dalla-Favera R
Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050029
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Non-Hodgkin's Lymphoma.
Thandra KC; Barsouk A; Saginala K; Padala SA; Barsouk A; Rawla P
Med Sci (Basel); 2021 Jan; 9(1):. PubMed ID: 33573146
[TBL] [Abstract][Full Text] [Related]
14. Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies.
Hernández-Verdin I; Labreche K; Benazra M; Mokhtari K; Hoang-Xuan K; Alentorn A
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374413
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]